Tom Bowen is a senior editor who loves adventure games and RPGs. He's been playing video games for several decades now and writing about them professionally since 2020. Although he dabbles in news and ...

A version of this article first appeared in CNBC's Healthy Returns newsletter, which brings the latest health-care news straight to your inbox. Subscribe here to receive future editions. Pfizer made ...

Pfizer hopes to differentiate itself in the obesity drug market with a once-monthly injection. The company plans to advance 20+ obesity therapy clinical studies in 2026. Pfizer's first potential ...

Pfizer signaled some promise in its long-running attempt to develop an anti-obesity drug on Tuesday, but analysts say limited results and missing safety information left Wall Street still uncertain ...

Pfizer's stock has declined 40% over the past three years, as it has struggled to attract investors. Investors appear to be underrating its growth prospects, as the company has a robust pipeline. Its ...

CHONGQING, CHINA - JANUARY 29: In this photo illustration, a smartphone displays the logo of Pfizer Inc. (NYSE: PFE), an American multinational pharmaceutical company engaged in the development, ...

Pfizer PFE0.04%increase; green up pointing triangle reported lower fourth-quarter sales as demand for its Covid-19 vaccine and antiviral drug continued to decline. The drugmaker reported a loss of ...

To stir up support for the fight against cancer, Pfizer has turned to one of the most iconic pep talks of all time. A new ad debuting on Wednesday’s World Cancer Day borrows several snippets from the ...

The stock price of BridgeBio plunged 15% Thursday as Pfizer’s reported decision to withdraw a tafamidis patent in the European Union triggered fears of earlier generic entry in the blockbuster ...

The last time I spoke about Pfizer (PFE) it was with respect to a Seeking Alpha article entitled "Pfizer: Downgrade To 'Hold' On Lower 2026 Revenue Guidance And Potential Growth Tracks". With respect ...